Alpha Cognition Inc. (ACOGF)
USD 5.73
(0.0%)
USD 5.73
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -9.7 Million USD | 27.42% |
| 2022 | -13.12 Million USD | -16.52% |
| 2021 | -11.03 Million USD | -104.9% |
| 2020 | -5.68 Million USD | -10.22% |
| 2019 | -5.08 Million USD | -15557.67% |
| 2018 | -32.45 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.23 Million USD | 58.28% |
| 2024 Q1 | -4.41 Million USD | 15.13% |
| 2023 Q1 | -1.95 Million USD | 41.71% |
| 2023 FY | - USD | 26.33% |
| 2023 Q2 | -2.68 Million USD | -37.47% |
| 2023 Q4 | -2.15 Million USD | 21.16% |
| 2023 Q3 | -2.73 Million USD | -1.57% |
| 2022 Q2 | -4.35 Million USD | -51.1% |
| 2022 Q1 | -2.88 Million USD | 31.25% |
| 2022 Q4 | -3.35 Million USD | -20.47% |
| 2022 FY | - USD | -16.52% |
| 2022 Q3 | -2.78 Million USD | 36.03% |
| 2021 FY | - USD | -104.9% |
| 2021 Q2 | -2.17 Million USD | -7.77% |
| 2021 Q1 | -2.01 Million USD | -1520.11% |
| 2021 Q4 | -4.19 Million USD | -36.96% |
| 2021 Q3 | -3.05 Million USD | -40.71% |
| 2020 Q4 | -124.53 Thousand CAD | 93.92% |
| 2020 Q3 | -2.04 Million USD | 0.0% |
| 2020 FY | - USD | -10.22% |
| 2019 Q4 | -8968.73 CAD | 99.1% |
| 2019 FY | - USD | -15557.67% |
| 2019 Q3 | -1 Million USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 86.337% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -63.7% |
| SQZ Biotechnologies Company | -64.14 Million USD | 84.868% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 44.124% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 110.321% |
| Mesoblast Limited | -62.38 Million USD | 84.444% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -531.855% |
| Genus plc | 73.7 Million USD | 113.169% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -46.798% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -173.629% |
| Marizyme, Inc. | -34.28 Million USD | 71.688% |
| ContraFect Corporation | -64.99 Million USD | 85.068% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -10.643% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -114.432% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -592.363% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -267.018% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -317.657% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -1773.502% |
| Accustem Sciences Inc. | -3.74 Million USD | -159.063% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 79.875% |
| EV Biologics, Inc. | -1.26 Million USD | -665.95% |
| Q BioMed Inc. | -617.62 Thousand USD | -1471.432% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 371.713% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1434.71% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -324.848% |
| Biomind Labs Inc. | -1.03 Million USD | -838.148% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 198.265% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -35.529% |
| Skye Bioscience, Inc. | -13.54 Million USD | 28.359% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -552.516% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -38722.404% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -149.866% |
| IMV Inc. | -35.52 Million USD | 72.678% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 38.842% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -287.92% |
| GB Sciences, Inc. | -1.41 Million USD | -583.548% |
| HST Global, Inc. | -5303.00 USD | -182920.95% |
| CSL Limited | 4.78 Billion USD | 100.203% |
| Halberd Corporation | -74.27 Thousand USD | -12966.413% |
| Enzolytics Inc. | -2.12 Million USD | -357.374% |
| Resverlogix Corp. | -11.74 Million USD | 17.343% |
| Affymax, Inc. | -14.29 Million USD | 32.105% |
| SYBLEU INC | -141.57 Thousand USD | -6755.642% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -216.864% |
| argenx SE | -216.02 Million USD | 95.507% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 82.462% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 897.502% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -547.512% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 2661.899% |
| AVAX Technologies, Inc. | -6.11 Million USD | -58.779% |
| Zenith Capital Corp. | -8.6 Million USD | -12.777% |
| Genscript Biotech Corporation | -248.71 Million USD | 96.098% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -55612.077% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -296.72% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -5413.783% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 75.514% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -235.564% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -827.601% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 144442.668% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -454.606% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -405.26% |
| BioStem Technologies, Inc. | -7.55 Million USD | -28.489% |
| ONE Bio Corp. | 13.61 Million USD | 171.296% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -5259.605% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -371.833% |
| Agentix Corp. | -1.37 Million USD | -607.531% |
| LadRx Corporation | 412.28 Thousand USD | 2454.111% |
| Cell Source, Inc. | -4.27 Million USD | -127.163% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -2542.986% |
| Regen BioPharma, Inc. | 1.46 Million USD | 762.066% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -935.873% |
| NovAccess Global Inc. | -1.03 Million USD | -837.923% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 209.621% |
| Itoco Inc. | -1.86 Million USD | -419.295% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -2456.662% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -769.678% |
| Kadimastem Ltd | -2.62 Million USD | -269.824% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -3958.374% |
| CytoDyn Inc. | -18.02 Million USD | 46.167% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -12181.063% |
| Mobile Lads Corp. | -2.24 Million USD | -333.062% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -79265.451% |
| Qrons Inc. | -40.08 Thousand USD | -24114.967% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -1898.361% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 1940.158% |
| Rebus Holdings, Inc. | -951 Thousand USD | -920.568% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -813.89% |
| International Stem Cell Corporation | 202 Thousand USD | 4904.753% |
| Bioxytran, Inc. | -3.82 Million USD | -154.064% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -18337.692% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -294.227% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 72.942% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -21468.002% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -254.478% |
| Neutra Corp. | -181.24 Thousand USD | -5254.903% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 51.855% |
| PureTech Health plc | -11.62 Million USD | 16.525% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 51.851% |
| IXICO plc | -707 Thousand USD | -1272.787% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -26.293% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 79.925% |
| CSL Limited | 4.73 Billion USD | 100.205% |
| Cellectis S.A. | -92.63 Million USD | 89.523% |